Medinotec Inc. operates primarily through its South African subsidiary, manufacturing specialized balloon catheter and airway dilation devices, including FDA-cleared products like Trachealator and Outflo. Its revenue remains highly concentrated in South Africa, principally through a key distributor, DISA Life Sciences, representing approximately 89% of sales as of fiscal year 2026. The company is actively expanding its U.S. commercial presence following FDA approvals but faces significant risks from regulatory hurdles, reliance on a narrow customer base, and operational challenges linked to its South African manufacturing footprint. Growth depends on regulatory success in new markets, product portfolio expansion, and execution on distribution strategies.